Dabigatran Etexilate

314 interactions 383 cited references

Read the full Dabigatran Etexilate drug information page

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 10, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Levoketoconazole Defibrotide Injection Defibrotide Dexketoprofen Oxaliplatin Injection Diclofenac

3 Contraindicated 282 Major 29 Moderate

All (314) Contraindicated (3) Major (282) Moderate (29)

Contraindicated

Dabigatran Etexilate Defibrotide Increased risk of bleeding Details Dabigatran Etexilate Levoketoconazole Recorlev Increased CYP3A4/P-gp substrate exposure Details Dabigatran Etexilate Defibrotide Injection Defitelio Increased risk of bleeding Details

Major

Dabigatran Etexilate Sertraline An increased risk of bleeding Details Dabigatran Etexilate Abrocitinib Cibinqo Increased dabigatran exposure and an increased risk of bleeding Details Dabigatran Etexilate Apixaban Eliquis An increased risk of bleeding and can cause serious, potentially fatal bleeding Details Dabigatran Etexilate Aspirin Acuprin® Increased risk of bleeding Details Dabigatran Etexilate Aspirin Rectal Aspirin Increased risk of bleeding Details Dabigatran Etexilate Azithromycin AzaSite Increased dabigatran exposure and an increased risk of bleeding Details Dabigatran Etexilate Betrixaban Bevyxxa® Increased risk of bleeding Details Dabigatran Etexilate Abiraterone Abirtega Increased dabigatran etexilate exposure Details Dabigatran Etexilate Alogliptin Nesina Increased dabigatran exposure and an increased risk of bleeding Details Dabigatran Etexilate Anagrelide Agrylin Increased risk of bleeding Details Dabigatran Etexilate Bromfenac Ophthalmic Bromday® An increased risk of bleeding Details Dabigatran Etexilate Canagliflozin Invokana Increased dabigatran exposure and an increased risk of bleeding Details Dabigatran Etexilate Caplacizumab-Yhdp Injection Cablivi An increased risk of bleeding Details Dabigatran Etexilate Capmatinib Tabrecta Increased dabigatran exposure and an increased risk of bleeding Details Dabigatran Etexilate Captopril Capoten® Increased dabigatran exposure and an increased risk of bleeding Details Dabigatran Etexilate Clopidogrel Plavix An increased risk of bleeding Details Dabigatran Etexilate Cyclosporine Injection Atopica Increased dabigatran exposure Details Dabigatran Etexilate Cyclosporine Ophthalmic Cequa Increased dabigatran exposure Details Dabigatran Etexilate Abciximab An increased risk of bleeding Details Dabigatran Etexilate Abiraterone Acetate Abirtega Increased dabigatran etexilate exposure Details Dabigatran Etexilate Abiraterone Acetate, Micronized Abirtega Increased dabigatran etexilate exposure Details Dabigatran Etexilate Aceclofenac An increased risk of bleeding Details Dabigatran Etexilate Acemetacin An increased risk of bleeding Details Dabigatran Etexilate Acenocoumarol An increased risk of bleeding Details Dabigatran Etexilate Adagrasib Krazati Increased dabigatran exposure and an increased risk of bleeding Details Dabigatran Etexilate Alipogene Tiparvovec An increased risk of bleeding Details Dabigatran Etexilate Alteplase, Recombinant Activase An increased risk of bleeding Details Dabigatran Etexilate Amiodarone Nexterone Increased dabigatran exposure and an increased risk of bleeding Details Dabigatran Etexilate Amtolmetin Guacil An increased risk of bleeding Details Dabigatran Etexilate Anistreplase An increased risk of bleeding Details Dabigatran Etexilate Apalutamide Erleada Reduced dabigatran exposure, reduced efficacy of dabigatran and an increased risk of thrombosis Details Dabigatran Etexilate Ardeparin An increased risk of bleeding Details Dabigatran Etexilate Argatroban An increased risk of bleeding Details Dabigatran Etexilate Asunaprevir Increased dabigatran exposure and an increased risk of bleeding Details Dabigatran Etexilate Atazanavir Reyataz Increased dabigatran etexilate exposure and an increased risk of bleeding Details Dabigatran Etexilate Bemiparin An increased risk of bleeding Details Dabigatran Etexilate Berotralstat Orladeyo Increased dabigatran exposure and an increased risk of bleeding Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.